Back to News
Market Impact: 0.22

Is Costco Stock Underperforming the Nasdaq?

COSTWMT
Consumer Demand & RetailCompany FundamentalsCapital Returns (Dividends / Buybacks)Analyst EstimatesMarket Technicals & FlowsInvestor Sentiment & Positioning
Is Costco Stock Underperforming the Nasdaq?

Costco shares are down 8.5% from their May 19 52-week high of $1,096.50 and have lagged the Nasdaq over both the past three months and the past 52 weeks. The company lifted its quarterly dividend from $1.30 to $1.47 per share, or $5.88 annualized, payable May 15, 2026, extending a 21-year dividend-paying streak. Wall Street remains moderately constructive, with 34 analysts rating the stock a "Moderate Buy" and a mean target of $1,093.90, implying about 9% upside.

Analysis

The important read-through is not the dividend itself, but that COST is entering a phase where valuation is being forced to reconcile with slower earnings momentum and a crowded ownership base. A mature defensive growth compounder can keep compounding sales while still derating if the marginal buyer was paying for near-perfect execution; the recent break below the shorter-term trend line suggests that process may already be starting. That matters because the stock’s relative underperformance versus broader retail strength implies investors are rotating toward names with cleaner near-term operating leverage, not abandoning retail altogether. WMT is the cleaner beneficiary of that rotation. If consumers remain value-seeking but become more selective, the market tends to reward the operator with more obvious share-gain evidence, not the premium multiple name with less room for surprise. Second-order, COST’s pricing power can stay intact while traffic growth normalizes, but that is exactly the kind of setup where multiple compression arrives before any fundamental deterioration shows up in reported comps. The contrarian point is that the pullback may be only a reset, not a thesis break. A stock that has been disconnected from fundamentals for a long time can absorb a 5-10% air pocket without changing the long-term story, and the dividend increase reinforces capital return discipline for patient holders. The key risk is time horizon: over days to weeks, technical sellers and factor rotation can dominate; over months, any re-acceleration in ticket growth or membership engagement would quickly re-anchor the premium multiple and squeeze shorts. From a positioning perspective, this is more attractive as a relative-value expression than an outright bearish call. The setup favors waiting for either a better entry on COST or confirmation that WMT is the stronger earnings revision story before adding risk.